Donghui Zhang

Donghui Zhang

Auto-generated profile, based on publicly available information

Donghui Zhang

Affiliation Zhanjiang Institute of Clinical Medicine, Central People’s Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, PR China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Chemical Engineering Journal
Verified
Journal Article
Closed access
SZShibo Zhang
Shibo Zhang
WZWanchao Zuo
Wanchao Zuo
PWPengcheng Wu
Pengcheng Wu
XMXiangming Meng
Xiangming Meng
CSCaixia Sun
Caixia Sun
YJYanmin Ju
Yanmin Ju

8 July 2023 in Talanta
Verified
Journal Article
Closed access
PWPengcheng Wu
Pengcheng Wu
JSJiaren Song
Jiaren Song
WZWanchao Zuo
Wanchao Zuo
JZJiaying Zhu
Jiaying Zhu
XMXiangming Meng
Xiangming Meng
YJYanmin Ju
Yanmin Ju

31 July 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
QYQing Yang
Qing Yang
WZWanchao Zuo
Wanchao Zuo
JSJiaren Song
Jiaren Song
SZSiqi Zeng
Siqi Zeng
XMXiangming Meng
Xiangming Meng
YJYanmin Ju
Yanmin Ju

25 June 2024 in Experimental Cell Research
Verified
Journal Article
Open access
DXDacai Xu
Dacai Xu
DZDonghui Zhang
Donghui Zhang
WWWenlu Wei
Wenlu Wei
CZChong Zhang
Chong Zhang
UBA5, a ubiquitin-like activated enzyme involved in ufmylation and sumoylation, presents a viable target for pancreatic and breast cancer treatments, yet its role in lung adenocarcinoma (LUAD) remains underexplored. This study reveals UBA5's tumor-promoting effect in LUAD, as evidenced by its upregulation in patients and positive correlation with TNM stages. Elevated UBA5 levels predict poor outcomes for these patients. Pharmacological inhibition of UBA5 using DKM 2-93 significantly curtails the growth of A549, H1299, and cisplatin-resistant A549 (A549/DDP) LUAD cells in vitro. Additionally, UBA5 knockdown via shRNA lentivirus suppresses tumor growth both in vitro and in vivo. High UBA5 expression adversely alters the tumor immune microenvironment, affecting immunostimulators, MHC molecules, chemokines, receptors, and immune cell infiltration. Notably, UBA5 expression correlates positively with M2 macrophage infiltration, the predominant immune cells in LUAD. Co-culture experiments further demonstrate that UBA5 knockdown directly inhibits M2 macrophage polarization and lactate production in LUAD. Moreover, in vivo studies show reduced M2 macrophage infiltration following UBA5 knockdown. UBA5 expression is also associated with increased tumor heterogeneity, including tumor mutational burden, microsatellite instability, neoantigen presence, and homologous recombination deficiency. Experiments indicate that UBA5 overexpression promotes cisplatin resistance in vitro, whereas UBA5 inhibition enhances cisplatin sensitivity in both in vitro and in vivo settings. Overall, these findings suggest that targeting UBA5 inhibits LUAD by impeding cancer cell proliferation, M2 macrophage polarization, and cisplatin resistance.

16 June 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DZDonghui Zhang
Donghui Zhang
CZChong Zhang
Chong Zhang
YZYanmei Zhu
Yanmei Zhu
HXHaixia Xie
Haixia Xie
CYCaifeng Yue
Caifeng Yue
YGYiting Guan
Yiting Guan
Defects in cilia genes, which are critical for cilia formation and function, can cause complicated ciliopathy syndromes involving multiple organs and tissues; however, the underlying regulatory mechanisms of the networks of cilia genes in ciliopathies remain enigmatic. Herein, we have uncovered the genome-wide redistribution of accessible chromatin regions and extensive alterations of expression of cilia genes during Ellis–van Creveld syndrome (EVC) ciliopathy pathogenesis. Mechanistically, the distinct EVC ciliopathy-activated accessible regions (CAAs) are shown to positively regulate robust changes in flanking cilia genes, which are a key requirement for cilia transcription in response to developmental signals. Moreover, a single transcription factor, ETS1, can be recruited to CAAs, leading to prominent chromatin accessibility reconstruction in EVC ciliopathy patients. In zebrafish, the collapse of CAAs driven by ets1 suppression subsequently causes defective cilia proteins, resulting in body curvature and pericardial oedema. Our results depict a dynamic landscape of chromatin accessibility in EVC ciliopathy patients, and uncover an insightful role for ETS1 in controlling the global transcriptional program of cilia genes by reprogramming the widespread chromatin state.

26 December 2025 in Nano Letters
Verified
Journal Article
Closed access
WZWanchao Zuo
Wanchao Zuo
XMXiangming Meng
Xiangming Meng
SZSiqi Zeng
Siqi Zeng
WWWenlu Wei
Wenlu Wei
QYQing Yang
Qing Yang
YJYanmin Ju
Yanmin Ju